HighTower Advisors
IDXX icon

HighTower Advisors’s Idexx Laboratories IDXX Stock Holding History

HighTower Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-300
Closed -$1K – 2358
2018
Q4 		$1K Hold
300
– – ﹤0.01% 2187
2018
Q3 		$1K Buy
+300
New +$72.8K ﹤0.01% 2263

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HighTower Advisors's IDXX Position: Q1 2026 in Review

HighTower Advisors increased its Idexx Laboratories (IDXX) stake by 3.7% in Q1 2026, buying an estimated $658K and bringing the position to 28,526 shares worth $16M. The position accounts for 0.02% of the portfolio, ranked #693.

HighTower Advisors first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.5M in Q4 2021. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • HighTower Advisors held 28,526 shares of Idexx Laboratories worth $16M as of Q1 2026.
  • HighTower Advisors bought 1,026 Idexx Laboratories shares in Q1 2026, an estimated $658K.
  • Idexx Laboratories made up 0.02% of HighTower Advisors's portfolio in Q1 2026, its #693 holding.
  • HighTower Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Idexx Laboratories position peaked at $24.5M in Q4 2021.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.